190 related articles for article (PubMed ID: 1931570)
21. Effective use of autoantibody tests in the diagnosis of systemic autoimmune disease.
Lyons R; Narain S; Nichols C; Satoh M; Reeves WH
Ann N Y Acad Sci; 2005 Jun; 1050():217-28. PubMed ID: 16014537
[TBL] [Abstract][Full Text] [Related]
22. Myositis in other connective tissue disorders.
Isenberg D
Clin Rheum Dis; 1984 Apr; 10(1):151-74. PubMed ID: 6610527
[TBL] [Abstract][Full Text] [Related]
23. A novel autoantibody to a 155-kd protein is associated with dermatomyositis.
Targoff IN; Mamyrova G; Trieu EP; Perurena O; Koneru B; O'Hanlon TP; Miller FW; Rider LG; ;
Arthritis Rheum; 2006 Nov; 54(11):3682-9. PubMed ID: 17075819
[TBL] [Abstract][Full Text] [Related]
24. Autoantibodies against a specific nuclear RNP protein in sera of patients with autoimmune rheumatic diseases associated with myositis.
Arad-Dann H; Isenberg DA; Shoenfeld Y; Offen D; Sperling J; Sperling R
J Immunol; 1987 Apr; 138(8):2463-8. PubMed ID: 3494067
[TBL] [Abstract][Full Text] [Related]
25. [Immunologic tests: Anti-polymyositis-scleroderma (PM-Scl) antibody].
Takasaki Y
Nihon Rinsho; 2005 Jul; 63 Suppl 7():502-4. PubMed ID: 16111314
[No Abstract] [Full Text] [Related]
26. Autoantibodies in systemic rheumatic disorders clinical and diagnostic relevance.
Genth E; Mierau R
Rev Rhum Engl Ed; 1997 Oct; 64(10 Suppl):149S-152S. PubMed ID: 9385666
[No Abstract] [Full Text] [Related]
27. Myositis and interstitial lung disease associated with autoantibody to a transfer RNA-related protein Wa.
Kajihara M; Kuwana M; Tokuda H; Yamane K; Kubo M; Hirakata M; Mimori T
J Rheumatol; 2000 Nov; 27(11):2707-10. PubMed ID: 11093458
[TBL] [Abstract][Full Text] [Related]
28. [Masking of pan-T-cell markers in patients with autoimmune diseases].
Grunow R; Volk HD; Schwaab J; Barthelmes H; Lande L; von Baehr R
Dermatol Monatsschr; 1987; 173(7):390-9. PubMed ID: 3498654
[No Abstract] [Full Text] [Related]
29. [Progress in laboratory tests of connective tissue diseases].
Yamane K; Kato S; Sakauchi M
Rinsho Byori; 1989 Dec; 37(12):1311-6. PubMed ID: 2614963
[TBL] [Abstract][Full Text] [Related]
30. [Clinico-immunological heterogeneity of idiopathic inflammatory myopathy].
Nasonov EL; Shtutman VZ; Salozhin KV; Guseva NG; Nasonova VA; Plotts P
Klin Med (Mosk); 1995; 73(2):3-8. PubMed ID: 7609412
[No Abstract] [Full Text] [Related]
31. Humoral immunity in polymyositis and dermatomyositis.
Targoff IN; Reichlin M
Mt Sinai J Med; 1988 Nov; 55(6):487-93. PubMed ID: 3068537
[No Abstract] [Full Text] [Related]
32. [Epidemiology of connective tissue diseases of the skin (scleroderma, dermatomyositis and polymyositis) in Japan].
Hatano H
Hautarzt; 1982 Jul; 33(7):355-8. PubMed ID: 7107279
[TBL] [Abstract][Full Text] [Related]
33. Anti-PM/Scl autoantibodies in patients without clinical polymyositis or scleroderma.
Schnitz W; Taylor-Albert E; Targoff IN; Reichlin M; Scofield RH
J Rheumatol; 1996 Oct; 23(10):1729-33. PubMed ID: 8895149
[TBL] [Abstract][Full Text] [Related]
34. Identification of a novel autoantibody reactive with 155 and 140 kDa nuclear proteins in patients with dermatomyositis: an association with malignancy.
Kaji K; Fujimoto M; Hasegawa M; Kondo M; Saito Y; Komura K; Matsushita T; Orito H; Hamaguchi Y; Yanaba K; Itoh M; Asano Y; Seishima M; Ogawa F; Sato S; Takehara K
Rheumatology (Oxford); 2007 Jan; 46(1):25-8. PubMed ID: 16728436
[TBL] [Abstract][Full Text] [Related]
35. Photoessay of the cutaneous manifestations of the idiopathic inflammatory myopathies.
Dugan EM; Huber AM; Miller FW; Rider LG;
Dermatol Online J; 2009 Feb; 15(2):1. PubMed ID: 19336018
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of specific autoantibodies in juvenile dermatomyositis.
Feldman BM; Reichlin M; Laxer RM; Targoff IN; Stein LD; Silverman ED
J Rheumatol; 1996 Oct; 23(10):1794-7. PubMed ID: 8895161
[TBL] [Abstract][Full Text] [Related]
37. [Interstitial lung disease in patients with connective tissue diseases].
Hirakata M; Nakamura K; Kaburaki J; Suwa A; Mimori T; Kanazawa M; Akizuki M
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Dec; 33 Suppl():268-76. PubMed ID: 8752518
[TBL] [Abstract][Full Text] [Related]
38. [Antinuclear and anticytoplasmic antibodies in 24 cases of dermatomyositis. Value of western blotting].
Meyer O; Aeschlimann A; Bourgeois P; Belmatoug N; Palazzo E; Haim T; Kahn MF
Ann Med Interne (Paris); 1989; 140(6):449-52. PubMed ID: 2696398
[TBL] [Abstract][Full Text] [Related]
39. The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis.
Yoshida S; Akizuki M; Mimori T; Yamagata H; Inada S; Homma M
Arthritis Rheum; 1983 May; 26(5):604-11. PubMed ID: 6405755
[TBL] [Abstract][Full Text] [Related]
40. Clinical implications of ribonucleoprotein antibody.
Rasmussen EK; Ullman S; Høier-Madsen M; Sørensen SF; Halberg P
Arch Dermatol; 1987 May; 123(5):601-5. PubMed ID: 3495241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
